Regulatory authorities may encourage the application of SA if there is a lack of clarity or hesitancy during drug development. They are typically introduced between pre-clinical and exploratory early phase clinical testing and can contribute to getting regulatory approval for studies, development programs and end products.
SGS is recognized as the leading early phase contract research organization (CRO). Whatever you drug development plan, we will support you throughout your SA interactions with regulators.
2nd Floor Alegria Office Building. 2229 Chino Roces Avenue,
1223,
Makati, Metro Manila, Philippines